Outlook Therapeutics, Inc.
OTLK—
Outlook Therapeutics, Inc.OTLK$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-1.79
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$1.41M
Net income
$-62.42M
Net margin
-4416.2%
Gross margin
4.0%
Dividends & financials
Outlook Therapeutics, Inc. (OTLK) reported revenue of $1.41M and net income of $-62.42M, or $-1.79 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.